How does Lecanemab compare to other Alzheimer's assets?
Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...
${alertText}
Want unlimited access? Try Pro free for 7 days.
How does Lecanemab compare to other Alzheimer's assets?
AUPH Settles Patent Disputes with Sun
Pro Biotech Weekly Catalyst Watchlist Jan 2nd 2022
Biotech Weekly Catalyst Watchlist Jan 2nd 2022
Biopharma Pulse - 12/26-12/30 Weekly Review
TGTX - BRIUMVI (Ublituximab) approval
Big/Suspected Movers FAQ/User Guide
Quarterly Big Mover Biotech Stocks To Watch
Q2 2023 Product Revenue Analyses
BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis
SYFOVRE (APLS) vs. IZERVAY (Astellas)
BIIB & SAGE: Zuranolone
Apellis Pharmaceuticals (APLS)
Our platform helps you uncover your next biotech investment opportunity